Cycurion declines a proposed 7-for-1 reverse stock split and says it will pursue forensic and regulatory action while focusing on business growth and revenue visibility.
Key Highlights:
- Board and management rejected a 7-for-1 reverse split, saying it would risk shareholder harm and not solve underlying valuation issues.
- Company reports organic revenue of approximately $15.5M and an annual revenue run rate near $28M.
- Completed acquisitions of Digital Ally (~$5.1M revenue) and Secuvant (~$2.5M) to expand recurring, higher-margin services.
- Secured a new 10-year contract valued at $58M and built about $8M of contracted backlog for multi-year visibility.
- Forensic review cites suspicious trading: 89.9M shares traded in one day vs ~86.5M float and concentrated short-exempt activity March 16–17, 2026; company is working with Nasdaq and may pursue remedies.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.